Dosage and administration
Take one capsule 60 minutes prior to sexual activity.
Take one capsule 60 minutes prior to sexual activity.
Take one capsule 60 minutes prior to sexual activity.
Consult with a physician to determine if this product is safe for you to use or not. This product contains Herbs, powders and extracts that can have an effect on your health. Do not take this product if you are taking any drug, drinking alcohol, had caffeine or any ingredient that increases energy or affects blood pressure higher or lower. This product is not intended to cure any disease or condition. Do not take if you have any heart issues, high blood pressure, liver issues, or any condition you are being treated for. Consult with your physician before you take this product or any sexual enhancement product.
Do not take more than one capsule every 24 hours.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseases. Not intended for use by person under the age of 18.
| SERVING SIZE: 1 CAPSULE | AMOUNT PER SERVING | % DAILY VALUE |
| NIACIN | 25 MG | 125% † |
| PYRIDOXINE HYDROCHLORIDE | 5 MG | 250% † |
| DL-ALPHA-TOCOPHEROL ACETATE | 10 MG | 33% † |
| ZINC OXIDE | 20 MG | 133% † |
| L-ARGININE HCL | 120 MG | * |
| LYCOPENE | 0.10 MG | * |
| PROPRITARY BLEND | 2,800 MG | * |
| KOREAN GINSENG PANAX (ROOT) | ||
| MACA (ROOT) | ||
| GINKGO BILOBA (LEAF) | ||
| TRIBULUS TERRESTRIS (FRUIT) | ||
| GUARANA (SEED) |
* Daily Values not established
† Percent daily values established based on 2,000 calories diet.
Microcrystalline Cellulose, Silicon Dioxide, Magnesium Stearate, Gelatin, Titanium Dioxide, FD&C Red 40
Manufactured by:
VitaCare Pharma LLC
South Plainfield, NJ 07080
| Class | Version | Type | Effective |
|---|---|---|---|
| NIACIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| e2dae634-14ed-febf-08ee-93196433b5b7 | Product name | 9 | 20190614 |
| 5e18e798-5614-cf5c-0185-38b1cb77a093 | Product name | 2 | 20160822 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 0a5e5249-329b-0cff-e714-77159f193a87 | Product name | 1 | 20140508 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
| 6b7a6f32-42a6-994d-5ab6-d180e92ee9d8 | Product name | 1 | 20140508 |
| d394f843-7479-dc48-dbd3-232266c5548c | Product name | 1 | 20140508 |
| dc9a5fb6-14e2-1cc8-a567-a781fd1f0212 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57688-006-61 | Day and Night Male Sexual Enhancer | 2 in 1 CASE | CAPSULE | 2 | 4 |
Every source-derived product name is available through these pages.
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| R-Gene | ARGININE HYDROCHLORIDE | Pharmacia & Upjohn Company LLC | 6accf33f-9841-4327-8923-93c42020ef12 | 2024-04-02 | Warnings, Adverse reactions | ARGININE HYDROCHLORIDE |
Adverse event summaries are temporarily unavailable. Other product information remains available.